Cargando…
Bactericidal activity of PA-824 against Mycobacterium tuberculosis under anaerobic conditions and computational analysis of its novel analogues against mutant Ddn receptor
BACKGROUND: The resurgence of multi-drug resistant tuberculosis (MDR-TB) and HIV associated tuberculosis (TB) are of serious global concern. To contain this situation, new anti-tuberculosis drugs and reduced treatment regimens are imperative. Recently, a nitroimidazole, PA-824, has been shown to be...
Autores principales: | Somasundaram, Sulochana, Anand, Ramaian Santhaseela, Venkatesan, Perumal, Paramasivan, Chinnambedu N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853930/ https://www.ncbi.nlm.nih.gov/pubmed/24083570 http://dx.doi.org/10.1186/1471-2180-13-218 |
Ejemplares similares
-
Structure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis Involved in Bioreductive Activation of PA-824
por: Cellitti, Susan E., et al.
Publicado: (2012) -
Structure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis Involved in Bioreductive Activation of PA-824
por: Cellitti, Susan E., et al.
Publicado: (2013) -
Comparison of in vitro Susceptibility of Mycobacteria Against PA-824 to Identify Key Residues of Ddn, the Deazoflavin-Dependent Nitroreductase from Mycobacterium tuberculosis
por: Zhang, Fuzhen, et al.
Publicado: (2020) -
Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis
por: Anand, RS, et al.
Publicado: (2011) -
Development of a less toxic dichloroacetate analogue by docking and descriptor analysis
por: Subramanian, Kannan, et al.
Publicado: (2010)